However, even though your body regulates electrolytes, it doesn’t create them, which is where the best electrolyte drinks can ...

Had Miller’s patients had mast cell activation syndrome this whole time? MCAS is a tricky disease to diagnose and treat, but it was something. An answer for the scientific community.

Barzolvolimab prevents the binding of stem cell factor to KIT to inhibit and deplete mast cells. The persistence of improvements 28 weeks after the last dose suggests a disease-modifying effect.

Quantum BioPharma Receives Ethics Committee Approval for Phase 2 Clinical Trial of FSD202 for Nociplastic Pain in Patients with Idiopathic Mast Cell Activation Syndrome ...

Phase 2 EvolvE presentation details: “Intraepithelial Mast Cells are Elevated in Active Eosinophilic Esophagitis and Correlate with Eosinophils: Baseline Data from a Randomized Controlled Trial of ...

Association of postural orthostatic tachycardia syndrome, hypermobility spectrum disorders, and mast cell activation syndrome in young patients; prevalence, overlap and response to therapy depends on ...

The degree of mast cell activation in patients with sickle cell disease may contribute to the heterogeneity of inflammation and chronic and acute complications. The potential role of basophils in ...

When mast cells become aggravated without clear allergens like pollen, or are triggered by a much broader range of things, it could be a case of Mast Cell Activation Syndrome (MCAS).

However, insufficient neoantigen-specific T-lymphocyte activation greatly limits their clinical efficacy. Here, we developed sericin-coordinated zinc ion-modified calcium phosphate (CP) nanovaccines ...

Discover 8 ways mast cell activation syndrome causes widespread symptoms from digestive issues to brain fog, often mistaken for other conditions.